COVID-19 (any condition) |
Treatment |
Treatment history [Treated with ACEi vs. Not received] |
Odds ratio: 0.960 (0.870-1.070)
§ |
Mancia
|
|
|
COVID-19 (severe/critical) |
Findings |
Chest Radiograph - Pulmonary infiltrates and/or Pleural effusions [Positive vs. Negative] |
Odds ratio: 8.010 (1.120-57.490)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Vital Signs |
Respiratory rate [1 unit increase vs. Not applicable] |
Odds ratio: 1.340 (0.950-1.880)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Vital Signs |
Heart rate [1 unit increase vs. Not applicable] |
Odds ratio: 0.960 (0.900-1.040)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Body temperature [Fever present vs. Normal] |
Odds ratio: 2.400 (0.950-6.050)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Dyspnea [Present vs. Not present] |
Odds ratio: 0.490 (0.080-3.130)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Anosmia/Hyposmia [Present vs. Not present] |
Odds ratio: 0.090 (0.010-0.740)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 4.230 (0.340-52.520)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 0.970 (0.900-1.040)
§ |
Yan
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Chinese female vs. White] |
Odds ratio: 0.750 (0.470-1.220)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Chinese male vs. White] |
Odds ratio: 1.180 (0.850-1.630)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Indian male vs. White] |
Odds ratio: 1.320 (1.150-1.530)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Indian female vs. White] |
Odds ratio: 1.430 (1.200-1.710)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Bangladeshi/Pakistani female vs. White] |
Odds ratio: 1.610 (1.310-1.970)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Bangladeshi/Pakistani male vs. White] |
Odds ratio: 1.810 (1.550-2.110)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Black female vs. White] |
Odds ratio: 1.890 (1.630-2.200)
§ |
Office for National Statistics
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Black male vs. White] |
Odds ratio: 1.930 (1.700-2.180)
§ |
Office for National Statistics
|
|
|
COVID-19 (severe/critical) |
Complications |
Hypoxia [Present vs. Not present] |
Odds ratio: 18.200 (9.362-35.380)
|
Lu
|
|
|
COVID-19 (severe/fatal) |
Symptoms |
Conjunctivitis [Present vs. Not present] |
Odds ratio: 3.390 (1.125-10.212)
|
Loffredo
|
|
|
SARS COV-2 infection |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.033 (1.029-1.037)
§ |
Liu
|
|
|
SARS COV-2 infection |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.158 (1.028-1.305)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Without chronic disease [Present vs. Not present] |
Odds ratio: 0.144 (0.115-0.181)
|
CDC
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [History of smoking vs. No history of smoking] |
Odds ratio: 3.770 (2.537-5.602)
|
CDC
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Pregnancy [Present vs. Not present] |
Odds ratio: 0.521 (0.191-1.421)
|
CDC
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 6.925 (5.510-8.705)
|
CDC
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [History of smoking vs. No history of smoking] |
Odds ratio: 3.050 (1.180-7.840)
|
Matsushita
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 1.750 (1.120-2.730)
§ |
Matsushita
|
|
|
COVID-19 (any condition) |
Other |
Average daily temperature [1 unit increase vs. Not applicable] |
Odds ratio: 0.810 (0.710-0.910)
§ |
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
NLR [Abnormal vs. Normal] |
Odds ratio: 2.886 (2.064-4.860)
§ |
Yang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Derived NLR ratio [Abnormal vs. Normal] |
Odds ratio: 1.901 (0.841-4.300)
§ |
Yang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Platelet-to-lymphocyte ratio [Abnormal vs. Normal] |
Odds ratio: 1.018 (0.988-1.749)
§ |
Yang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CRP [Abnormal vs. Normal] |
Odds ratio: 1.206 (0.898-2.045)
§ |
Yang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
WBC [Abnormal vs. Normal] |
Odds ratio: 1.118 (0.888-1.543)
§ |
Yang
|
|
|
COVID-19 (any condition) |
Patient characteristics |
Proportion of Black residents [1 unit increase vs. Not applicable] |
Odds ratio: 1.220 (1.090-1.400)
§ |
Li
|
|
|
COVID-19 (death) |
Comorbidities |
Cerebrovascular disease [Present vs. Not present] |
Odds ratio: 2.330 (0.770-7.040)
|
Aggarwal
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cerebrovascular disease [Present vs. Not present] |
Odds ratio: 2.550 (1.180-5.510)
|
Aggarwal
|
|
|
COVID-19 (death) |
Treatment |
Concomitant medication [Treated with Statins vs. Not received] |
Odds ratio: 0.350 (0.240-0.520)
§ |
Mehra
|
|
|
COVID-19 (death) |
Treatment |
Concomitant medication [Treated with ARBs vs. Not received] |
Odds ratio: 1.230 (0.870-1.740)
§ |
Mehra
|
|
|
COVID-19 (death) |
Treatment |
Concomitant medication [Treated with ACEi vs. Not received] |
Odds ratio: 0.330 (0.200-0.540)
§ |
Mehra
|
|
|
COVID-19 (death) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.790 (1.290-2.470)
§ |
Mehra
|
|
|
COVID-19 (death) |
Comorbidities |
COPD [Present vs. Not present] |
Odds ratio: 2.960 (2.000-4.400)
§ |
Mehra
|
|
|
COVID-19 (death) |
Complications |
Arrhythmia [Present vs. Not present] |
Odds ratio: 1.950 (1.330-2.860)
§ |
Mehra
|
|
|
COVID-19 (death) |
Comorbidities |
Heart failure [Present vs. Not present] |
Odds ratio: 2.480 (1.620-3.790)
§ |
Mehra
|
|
|
COVID-19 (death) |
Comorbidities |
Coronary artery disease [Present vs. Not present] |
Odds ratio: 2.700 (2.080-3.510)
§ |
Mehra
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Female vs. Male] |
Odds ratio: 0.790 (0.650-0.950)
§ |
Mehra
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>65 years vs. <=65 years] |
Odds ratio: 1.930 (1.600-2.410)
§ |
Mehra
|
|
|
COVID-19 (severe/critical) |
Status |
Hospital lenght of stay [1 day increase vs. Not applicable] |
Odds ratio: 1.010 (1.000-1.020)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Status |
Time from symptom onset to hospital admission [1 day increase vs. Not applicable] |
Odds ratio: 1.010 (0.970-1.060)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Body temperature [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.440 (1.110-1.890)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Vital Signs |
Respiratory rate [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.230 (1.080-1.390)
§ |
Yan
|
|
|